Trials / Completed
CompletedNCT01459042
Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China
Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension:An Observational Study in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-10-01
- First posted
- 2011-10-25
- Last updated
- 2011-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01459042. Inclusion in this directory is not an endorsement.